Approval of esketamine for treatment-resistant depression - Authors' reply
- PMID: 32087802
- DOI: 10.1016/S2215-0366(20)30040-7
Approval of esketamine for treatment-resistant depression - Authors' reply
Comment on
-
Approval of esketamine for treatment-resistant depression.Lancet Psychiatry. 2020 Mar;7(3):232-235. doi: 10.1016/S2215-0366(19)30533-4. Lancet Psychiatry. 2020. PMID: 32087801 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources

